e-ISSN: 2394-2967
logo

British Journal of Medical and Health Research

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

Volume 6, Issue 10 - 2019 (October 2019 Issue 10)

Volume 6 Issue 10 Cover

Issue Details:

Volume 6 Issue 10
Published:Invalid Date

Editorial: October 2019 Issue 10

Welcome to the 2019 issue of British Journal of Medical and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr Hemangi J Patel
Editor-in-Chief
British Journal of Medical and Health Research

Articles in This Issue

Showing 3 of 3 articles
Research PaperID: BJMHR0610001

POSSIBLE AMELIORATIVE EFFECTS OF MORINGA OLIFERA IN INHIBITING TOXICITY OF ADRIAMYCIN IN MALE RATS

Abd-El-karim Mohamed Abd-Lateif, Ahmad Ali Kandeel, BASMA ADEL KELANI, Khalid Haussen Zaghloul

Objective: The present investigation aimed to study the protective effects of aqueous extract of Moringa olifera (MOR) leaf powder against the side effects of Adriamycin ADR (an anthracycline antibiotic, used in tumor therapy) on the hematological and biochemical functions of male albino rats. Animal's studies and drug treatment: 48 male albino rats weighing 180 ± 10.0 gm were taken and divided into six groups each one consists of 8 male rats. The 1st group was fed adlibitum with saline without any treatment so called control. The 2nd group received MOR leaf powder aqueous extract orally with a daily dose 144 mg/Kg body weight for 30 days. The 3rd one is ADR group where the animals were injected intraperitoneal (IP) from the first day in six equal injections of ADR (each containing 3 mg/kg b.wt.) over a period of two weeks (total cumulative dosage of 18 mg/kg body weight). The 4th is ADR then MOR post-treated group where animals administered the same six injections of ADR dose of thereafter they were given the aqueous MOR leaf powder extract orally from day 20. The 5th is ADR/MOR treated group where animals received six equal injections of ADR over a period of 19 days and given concomitant orally a daily dose of MOR leaf powder aqueous extract of 144 mg/kg of body weight for 30 days. The 6th group was (MOR pretreated then ADR group) where animals given orally once daily dose of MOR aqueous extract of 144 mg/Kg b.wt for 30 days and at the 11th day received the six equal injections of ADR over a period of 19 days. The results revealed loss in body weight, an increase in mortality rate, disturbances in hematological parameters, liver and kidney functions of rats treated with adriamycin. In contrast, the Moringa improves the studied parameters to levels more or less similar to that of control group. Conclusions: This study revealed that Moringa may ameliorate the effect of ADR especially in the group that pretreated with Moringa before Adriamycin treatment.

AdriamycinMoringaBlood parametersliver and kidney functionshistopathologyrats.
37,529 views
11,245 downloads

Contributors:

 Abd-El-karim Mohamed Abd-Lateif
,
 Ahmad Ali Kandeel
,
 BASMA ADEL KELANI
,
 Khalid Haussen Zaghloul
Research PaperID: BJMHR0610002

ANALGESIC, ANTI-INFLAMMATORY AND ANTI-ARTHRITIC EFFECTS OF SIDDHA HERBO-MINERAL FORMULATION ‘THIRILOGA CHINDHAMANI PILLS’ IN ANIMAL MODELS

Anlin Michel, NALINA SARASAWATHI Kolappan, Velpandian V

ABSTRACT Thiriloga Chindhamani Pills (TCP) is commonly used in Siddha system of medicine for its analgesic, anti-inflammatory and anti-arthritic properties. However, these activities have not been scientifically validated through experimental procedures and clinical trials. So the present work was carried out to evaluate the above activities of TCP in rats. Hot Plate model was used to determine the analgesic activity. Two doses of TCP (100 mg and 200 mg/kg) was used and Diclofenac Sodium was used as standard. Among the two doses 200mg/kg showed highly significant analgesic activity indicated the analgesic activity of TCP in dose dependent manner. Evaluation of anti-inflammatory activity was carried out by carrageenan induced acute inflammatory model in rats. TCP100, TCP200 and reference drug Indomethacin was administered. The results showed that there was a significant difference in oedema size between all the tested groups. TCP 200 exhibited highly significant effect which is similar to that of standard drug. Evaluation of the antiarthritic activity of TCP was evaluated on Freund's complete adjuvant induced arthritic model. Two doses of TCP (100 and 200 mg / kg) and the reference drug Prednisolone 10mg/kg were administered. Both the positive control and two doses of Thiriloga Chindhamani Pills decreased the inflammatory process and TCP 200 significantly decrease the inflammation when compared to the control. This work has shown that Thiriloga Chindhamani Pills have analgesic, anti-inflammatory and anti-arthritic activities, which would justify their traditional use in Siddha system of medicine.

Key words: Thiriloga Chindhamani PillsAnalgesic activityAnti-inflammatory activityAnti-arthritic activity
37,733 views
11,394 downloads

Contributors:

 Anlin Michel
,
 NALINA SARASAWATHI Kolappan
,
 Velpandian V
Research PaperID: BJMHR0610003

Anaplastic Carcinoma In A Young Female: An Incidental Finding In A Colloid Goitre

Kafil Akhtar, Shagufta . Shahin, Anjum . Ara, Sadaf . Haiyat

Anaplastic carcinomas are the lethal thyroid neoplasms and have poor survival rate and prognosis. Pre existing well differentiated thyroid neoplasms can give rise to anaplastic carcinoma. Here, we report a case of anaplastic carcinoma in a young female in a colloid goitre as an incidental finding diagnosed by histopathological examination. Thyroid function tests showed suppressed TSH and elevated FT4 and FT3. Anti-thyroid hormone drugs were started. Thyrotropin receptor antibody was negative. USG neck showed single hypoechoic lesion in the periphery of the right lobe. A thyroid scan revealed focal hot and cold nodules and fine needle aspiration biopsy (FNAB) of the thyroid gland showed colloid nodule. Patient underwent right side lobectomy and final histopathology showed anaplastic thyroid carcinoma. Our case is interesting from a pathophysiologic perspective, since it suggests that nodular goiter can be associated with an aggressive form of thyroid carcinoma. We would like to emphasize that there should be a high index of suspicion in patients with nodular goiter for careful evaluation to detect any associated cancer.

Anaplastic carcinomaColloid goitreIncidentalThyroid
38,045 views
11,365 downloads

Contributors:

 Kafil Akhtar
,
 Shagufta . Shahin
,
 Anjum . Ara
,
 Sadaf . Haiyat